Difficult Discharges to Skilled Nursing Facilities Attributed to Multiple Sclerosis Medications: An Observational Study.
Multiple Sclerosis Literature
Publication date: Apr 01, 2020 The costs of multiple sclerosis (MS) disease-modifying therapies (DMTs) and certain symptomatic treatments (ie, dalfampridine ) are high. Consolidated billing models require that medication costs ... Read more